Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 22, Issue 6 , Pages 1075-1088 , December 2008

Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage

  • S. Pavord, FRCP, FRCPath

      Affiliations

    • Corresponding Author InformationCorresponding author.

References 

  1. Conklin K, Backus A. Physiological changes of pregnancy. In:  Chestnut DH editors. Obstetric anesthesia: principles and practice. 2nd ed.. St Louis: Mosby; 1999;p. 17–42
  2. Taylor FB, Toh CH, Hoots WK, et al., Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)  Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330
  3. Bakhtiari K, Meijers JCM, de Jonge E, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32:2416–2421
  4. Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006;4:4
  5. British Committee for Standards in Haematology Blood Transfusion Task Force . Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001;113:24–31
  6. Guidelines for the blood transfusion services in the United Kingdom. 7th ed.. TSO; 2005;
  7. Hiippala S. Replacement of massive blood loss. Vox Sang. 1998;74:399–407
  8. Slichter SJ. Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program. 2007;172–178
  9. British Committee for Standards in Haematology , Stainsby D, MacLennan S, Thomas J, et al. Guidelines on the management of massive blood loss. Br J Haematol. 2006;135(5):634–641
  10. Johansson PI, Stensballe J, Rosenberg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47:593–598
  11. Handbook for transfusion medicine. 4th ed.. TSO; Jan 2007;
  12. Maegele M, Lefering R, Yucel N, et al., AG Polytrauma of the German Trauma Society (DGU)  Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38:298–304
  13. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. Jul 2003;55(1):39–44
  14. Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 2007; 2007: 179–186.
  15. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805–813
  16. Doyle S, O'Brien P, Murphy K, et al. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis. 2003;14:283–287
  17. Williamson LM, Llewelyn CA, Fisher NC, et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion. 1999;39:1227–1234
  18. Magner JJ, Crowley KJ, Boylan JF. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth. 2007;21(3):410–413
  19. Charbit B, Mandelbrot L, Samain E, et al., PPH Study Group  The decrease in fibrinogen is an early predictor of the severity of postpartum haemorrhage. J Thromb Haemost. 2007 Feb;5(2):266–273
  20. Kreuz W, Meili E, Peter-Salonen K, et al. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci. 2005;32:247–253
  21. Haas T, Fries D, Velik-Salchner C, et al. Fibrinogen in craniosynostosis surgery. Anesth Analg. 2008 Mar;106(3):725–731
  22. Burtelow M, Riley E, Druzin M, et al. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 2007;47(9):1564–1572
  23. As AK, Hagen P, Webb JB. Tranexamic acid in the management of postpartum haemorrhage. Br J Obstet Gynaecol. December 1996;103:1250–1251
  24. Bøe Engelsen Ingeborg, Albrechtsen Susanne, Erik Iversen Ole. Peripartum hysterectomy-incidence and maternal morbidity. Acta Obstet Gynecol Scand. 2001;80(5):409–412
  25. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339:245–253
  26. Valentine S, Williamson P, Sutton D. Reduction of acute haemorrhage with aprotinin. Anaesthesia. 1993;48:405–406
  27. Hedner U. Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis. 1990;1(3):307–317
  28. Alfirevic Z, Elbourne D, Pavord S, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the northern European registry 2000–2004. Obstet Gynecol. 2007;110:1270–1278
  29. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet. 2003 Jan 18;361(9353):201–205
  30. Sachs B, Delacy D, Green J, et al. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. Spine. 2007 Oct 1;32(21):2285–2293
  31. Rizoli SB, Boffard KD, Riou B, et al., the NovoSeven Trauma Study Group  Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care. 2006;10(6):R178
  32. McMorrow RC, Ryan SM. Use of recombinant factor VIIa in massive post-partum haemorrhage. Eur J Anaesthesiol. 2008 Apr;25(4):293–298
  33. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesthesiol Scand. 2007 Aug;51(7):929–936
  34. Hossain N, Shamsi T, Haider S, et al. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol Scand. 2007 Aug 29;1–7
  35. Scarpelini S, Nascimento B, Tien H, et al. Overview on the use of recombinant factor VIIa in obstetrics and gynecology. Exp Rev Obstet Gynecol. 2007;2(2):217–226
  36. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG. 2007;114(1):8–15
  37. Isbister J, Phillips L, Dunkley S. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register. Intern Med J. 2008 Mar;38(3):156–165
  38. Recombinant human activated factor VII as salvage therapy in women with severe postpartum hemorrhage. Available from: http://clinicaltrials.gov/ct/show/NCT00370877?order=5

PII: S1521-6934(08)00106-5

doi: 10.1016/j.bpobgyn.2008.08.010

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 22, Issue 6 , Pages 1075-1088 , December 2008

Article Tools